Product
Ad4-Env145NFL
2 clinical trials
2 indications
Indication
Healthy VolunteerIndication
HIVClinical trial
Phase I Open-Label Study of Safety and Immunogenicity of AD4-HIV Envelope Vaccine Vectors in Healthy VolunteersStatus: Recruiting, Estimated PCD: 2025-04-15
Clinical trial
A First-in-human Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 16055 NFL Delta Gly4 Env Protein Trimer and Trimer 4571 Combined With 3M-052-AF + Alum Adjuvant and Ad4-Env145NFL Viral Particles as Heterologous Prime-boost Regimens in Adult Participants Without HIVStatus: Recruiting, Estimated PCD: 2026-11-11